Canada Pension Plan Investment Board Has $524,000 Stock Holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Posted by Defense World Staff on Mar 2nd, 2023

Canada Pension Plan Investment Board decreased its holdings in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Get Rating) by 90.4% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 18,500 shares of the medical instruments supplier’s stock after selling 175,001 shares during the period. Canada Pension Plan Investment Board’s holdings in DENTSPLY SIRONA were worth $524,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in XRAY. Nuance Investments LLC raised its holdings in shares of DENTSPLY SIRONA by 356.3% in the second quarter. Nuance Investments LLC now owns 9,051,338 shares of the medical instruments supplier’s stock valued at $323,404,000 after purchasing an additional 7,067,751 shares during the last quarter. Wellington Management Group LLP raised its holdings in shares of DENTSPLY SIRONA by 83.1% in the first quarter. Wellington Management Group LLP now owns 5,502,424 shares of the medical instruments supplier’s stock valued at $270,829,000 after purchasing an additional 2,497,773 shares during the last quarter. Lazard Asset Management LLC raised its holdings in shares of DENTSPLY SIRONA by 11,805,127.3% in the second quarter. Lazard Asset Management LLC now owns 1,298,575 shares of the medical instruments supplier’s stock valued at $46,397,000 after purchasing an additional 1,298,564 shares during the last quarter. Artisan Partners Limited Partnership raised its holdings in shares of DENTSPLY SIRONA by 9.3% in the second quarter. Artisan Partners Limited Partnership now owns 12,758,726 shares of the medical instruments supplier’s stock valued at $455,869,000 after purchasing an additional 1,089,244 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD raised its holdings in shares of DENTSPLY SIRONA by 10.0% in the second quarter. Price T Rowe Associates Inc. MD now owns 9,987,997 shares of the medical instruments supplier’s stock valued at $356,871,000 after purchasing an additional 905,001 shares during the last quarter. Hedge funds and other institutional investors own 98.52% of the company’s stock.

DENTSPLY SIRONA Price Performance

Shares of NASDAQ:XRAY opened at $37.36 on Thursday. The company has a quick ratio of 1.04, a current ratio of 1.62 and a debt-to-equity ratio of 0.48. The firm has a market capitalization of $8.03 billion, a PE ratio of 14.26, a P/E/G ratio of 5.22 and a beta of 0.92. DENTSPLY SIRONA Inc. has a twelve month low of $26.48 and a twelve month high of $55.32. The company has a 50-day moving average price of $35.34 and a two-hundred day moving average price of $32.52.

DENTSPLY SIRONA (NASDAQ:XRAY – Get Rating) last issued its earnings results on Tuesday, February 28th. The medical instruments supplier reported $0.46 earnings per share for the quarter, topping analysts’ consensus estimates of $0.32 by $0.14. The firm had revenue of $983.00 million during the quarter, compared to analyst estimates of $939.11 million. DENTSPLY SIRONA had a negative net margin of 24.35% and a positive return on equity of 8.71%. The company’s quarterly revenue was down 10.9% on a year-over-year basis. During the same quarter last year, the business earned $0.76 earnings per share. Equities analysts forecast that DENTSPLY SIRONA Inc. will post 1.85 EPS for the current year.

DENTSPLY SIRONA Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 14th. Stockholders of record on Friday, March 31st will be given a $0.125 dividend. The ex-dividend date of this dividend is Thursday, March 30th. This represents a $0.50 dividend on an annualized basis and a dividend yield of 1.34%.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on XRAY shares. The Goldman Sachs Group increased their target price on shares of DENTSPLY SIRONA from $34.00 to $39.00 and gave the company a “neutral” rating in a report on Wednesday. Robert W. Baird decreased their price objective on shares of DENTSPLY SIRONA to $32.00 in a report on Thursday, November 17th. Barrington Research raised their price objective on shares of DENTSPLY SIRONA from $40.00 to $43.00 in a report on Wednesday. TheStreet upgraded shares of DENTSPLY SIRONA from a “d+” rating to a “c” rating in a report on Tuesday. Finally, William Blair upgraded shares of DENTSPLY SIRONA from an “underperform” rating to a “market perform” rating in a report on Wednesday, January 11th. Seven research analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Hold” and an average price target of $39.33.

About DENTSPLY SIRONA

(Get Rating)

Dentsply Sirona, Inc engages in the design, manufacture, sales and distribution of professional dental products and technologies. It operates through the following segments: Technologies and Equipment and Consumables. The Technologies and Equipment segments comprises dental technology, equipment and healthcare consumable products such as dental implants, laboratory dental products, computer-aided design and computer-aided manufacturing systems, imaging systems, treatment centers and consumable medical device products.